Corporate
Description
  • Value proposition

    Philosophy
    The purpose of the Shionogi Group's corporate activities is, as expressed in the opening of its Company Policy, to "supply the best possible medicine to protect the health and wellbeing of the patients we serve."​ This eternal and unwavering corporate philosophy is a statement of our vision and value to society. To achieve and live by the Company Policy, we have formulated Action Guidelines, which all Shionogi employees share and embrace as norms for daily activities. Through activities based on the Company Policy and the Action Guidelines, Shionogi will continue to contribute to patients, physicians and other healthcare providers, shareholders and investors, and furthermore to society as a whole.

Entity interactions BETA
Entity TypeTweets Articles
Orchid Pharma Orchid Pharma
Other

31 May 2024


Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA)
deeptech
Other

30 May 2024


Global Antibiotic R&D Partnership (GARDP) Global Antibiotic R&D Partnership (GARDP)
healthtech, Research Services
Other

2 Oct 2024


CARB-X CARB-X
deeptech, healthtech
Other

28 May 2024


FRAXA Research Foundation FRAXA Research Foundation
deeptech
Other

25 Sep 2024


National Fragile X Foundation National Fragile X Foundation
deeptech
Other

25 Sep 2024


Tetra Therapeutics, a SHIONOGI Group Company Tetra Therapeutics, a SHIONOGI Group Company
biotech, deeptech
Other

6 Mar 2024


Qpex Biopharma Qpex Biopharma
biotech, deeptech
Other

8 Oct 2024


Apnimed Apnimed
biotech, deeptech
Other

18 Dec 2023


Global Coalition on Aging Global Coalition on Aging
consulting
Other

2 Jul 2024


Radars
Loading...